Turing CEO Martin Shkreli, whose company jacked up drug price, is in custody after securities probe

December 17, 2015 1:55 PM

32 0

Martin Shkreli, the former hedge-fund manager under fire for buying a pharmaceutical company and ratcheting up the price of a life-saving drug, is in custody following a securities probe.

Calls to an attorney that has represented Shkreli in the past were not immediately returned. His arrest was confirmed Thursday by FBI spokeswoman Kelly Langmesser.

Read more

To category page